secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2026-10-09T20:30:24+00:00
Accession:  0001213900-26-108501
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

iSpecimen holders approve dilutive financings and Foldlab AI asset deal; reverse-split vote adjourned to Oct 30
--------------------------------------------------------------------------------

- Special meeting held Oct 9, 2026 drew 1,287,547 shares (51.1%) of 2,518,590 outstanding, constituting a quorum.
- Proposal 2, a reverse split of 1:10 to 1:100 at the board's discretion, was adjourned to Oct 30, 2026 at 10:00 a.m. ET; record date remains Aug 12, 2026 and prior proxies stay valid.
- Stockholders approved Nasdaq Rule 5635(d) issuance of shares underlying Pre-Funded Warrants from the May 8, 2026 Securities Purchase Agreement; vote was 779,705 for, 33,092 against.
- Proposal 3 approved 782,722 to 30,099: future convertible/equity-linked financings over 12 months at discounts up to 80% off the lowest VWAP, including warrants, resets and MFN rights.
- Proposal 4 approved 791,600 to 21,269 for the asset acquisition from Foldlab AI Ltd. under the Sept 4, 2026 Asset Purchase Agreement, partly payable in common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000121390026108501/0001213900-26-108501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000121390026108501/ea0308253-8k_ispaceimen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-108501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer